21Shares Files New INJ ETF as Institutional Interest Surges in Injective

TLDR:

• 21Shares filed a new INJ ETF, joining Canary and Rex Osprey ETFs in progress for the token.
• Injective’s 24-hour trading volume rose 5.4%, hitting $79.4 million, showing increased market activity.
• INJ price ranged from $7.81 to $10.04 over the past week, currently trading at $8.80.
• Staking activity continues to climb as holders maintain positions despite recent market declines.
  

---

Injective (INJ) is attracting growing attention from institutional investors after 21Shares filed a new ETF for the token. 

The filing marks INJ as one of the few digital assets with multiple ETF products in progress. Market activity for Injective is also rising, with trading volume increasing over the past 24 hours. 

Staking participation remains strong even after price dips, signaling steady confidence among holders. Tweets from the crypto community confirm that institutional and retail participants are closely watching the asset’s development.

Institutional ETF Interest Drives $INJ Market Focus

21Shares’ latest filing positions Injective alongside Canary and Rex Osprey ETFs, reinforcing the token’s appeal to large investors. 

Injective reported a 24-hour trading volume of $79,488,333, a 5.4% increase from the previous day, according to CoinGecko. 

Crypto commentator John_dgreatestt noted that multiple ETF filings reflect growing trust in INJ by institutional players. Increased liquidity could help Injective gain mainstream recognition as market participants pay closer attention to price movements.

Institutional involvement also signals potential changes in trading patterns for the token. 

Gemtoast highlighted that INJ staking activity is rising daily. Investors continue holding their positions despite recent price corrections, suggesting confidence in the long-term outlook. 

Analysts note that such developments could stabilize market sentiment while encouraging further adoption among institutional funds.

Injective Price Trends and Market Activity

Injective’s price fluctuated between $7.81 and $10.04 over the last week, closing at $8.80 during the latest trading session. 

The token gained 1.75% in the past 24 hours while maintaining higher trading activity than the previous day. These movements such as ETFs often create increased demand for the underlying asset. 

Community discussions emphasize that rising staking numbers demonstrate a committed user base supporting Injective’s ecosystem.

Price data combined with rising ETF interest could signal new trading dynamics. Institutional filings often drive short-term liquidity spikes while encouraging holders to stake or increase exposure. 

Tweets from the community reinforce that investors are actively monitoring both price and adoption metrics. Market participants now weigh staking activity alongside potential ETF inflows when evaluating $INJ performance.

The post 21Shares Files New INJ ETF as Institutional Interest Surges in Injective appeared first on Blockonomi.